A KETOGENIC DIET PROMOTES BLOOD-SPINAL CORD BARRIER RESEALING TO DECREASE SPINAL CORD IMMUNE CELL INFILTRATION IN A PRECLINICAL MODEL OF MULTIPLE SCLEROSIS.

A medium-chain triglyceride and omega-3 fatty acid-rich ketogenic diet accelerates blood-spinal cord barrier resealing and modulates immune cell populations to reduce inflammation and promote functional recovery in a preclinical model of multiple sclerosis.

The Gist

Imagine your body's central nervous system (your brain and spinal cord) is a high-security fortress. To keep this fortress safe, it has a super-tight security fence called the Blood-Spinal Cord Barrier (BSCB). This fence normally keeps the "bad guys" (harmful immune cells) out while letting the "good guys" (nutrients and oxygen) in.

In a disease like Multiple Sclerosis (MS), this security fence gets breached. The gates are left wide open, and an army of inflammatory cells rushes in, causing chaos, damaging the fortress walls (myelin), and stopping the signals from getting through. This causes the symptoms of MS, like weakness, numbness, and vision loss.

This paper investigates a surprising new way to fix the fence: a Ketogenic Diet (KD).

Here is the story of what the researchers found, explained simply:

1. The "Emergency Diet"

The researchers didn't just feed mice this diet to prevent the disease; they waited until the mice were already sick (showing symptoms) and then switched them to the diet. Think of it like calling a fire department after the fire has started, rather than just buying a fire extinguisher beforehand.

The diet is high in healthy fats and very low in carbs (sugar/starch). It forces the body to burn fat for fuel instead of sugar, creating "ketones" (a type of clean-burning fuel).

2. The "Traffic Jam" Outside the Gate

When the mice started the diet, something weird happened first. The "bad guys" (specifically neutrophils and monocytes, which are types of white blood cells) didn't disappear immediately. Instead, they got stuck outside the fortress in the bloodstream.

• The Analogy: Imagine a riot happening outside a stadium. Usually, the rioters rush the gates and get inside. But with the diet, the gates suddenly slammed shut so fast that the rioters were stuck in the parking lot, unable to get in.
• The Result: Because the immune cells couldn't get inside the spinal cord, the damage stopped. The mice started walking and moving better within just a few days.

3. The "Super Glue" Effect

Why did the gates slam shut? The diet acted like super glue for the security fence.

• The Mechanism: The disease produces a toxic chemical called IL-1β (think of it as a corrosive acid that melts the fence). The diet drastically reduced the amount of this acid.
• The Fix: With less acid, the fence could heal itself much faster. The researchers found that the diet helped reseal the barrier in both male and female mice, stopping the invasion of harmful cells.

4. Not All Soldiers Are the Same

Here is the most interesting part: The diet didn't just kill all the immune cells. It was very selective.

• The "Bad" Soldiers: The diet reduced the number of aggressive, angry immune cells by over 90%. These were the ones causing the destruction.
• The "Good" Soldiers: However, the diet kept a special group of immune cells that act like peacekeepers and construction workers. These cells have different "badges" (surface markers) that tell them to stop fighting and start repairing the damage.
• The Analogy: It's like the diet fired the violent rioters but kept the medics and the construction crew to fix the broken walls.

5. Does It Work If You Start Late?

The researchers tested if this diet still worked if they waited a whole week after the symptoms started before feeding it to the mice.

• The Verdict: Yes! Even when started late, the diet still managed to seal the fence and help the mice recover. This is huge news because it suggests that people with MS who are having a sudden "flare-up" (a relapse) could potentially use this diet to help calm things down quickly, even if they didn't start it earlier.

The Big Picture

This study suggests that the Ketogenic Diet isn't just about weight loss; it's a powerful tool for repairing the body's security system.

By changing what we eat, we can:

1. Stop the leak: Seal the holes in the blood-brain/spinal cord barrier.
2. Turn off the alarm: Reduce the toxic chemicals that keep the immune system angry.
3. Recruit the repair crew: Keep the helpful cells that fix damage while kicking out the destructive ones.

While this was done in mice, the findings offer a hopeful new path for understanding how simple dietary changes could help heal the nervous system in humans with MS and other neurodegenerative diseases. It's like realizing that sometimes, the best medicine isn't a pill, but a plate of food.

Technical Summary

1. Problem Statement

Multiple Sclerosis (MS) is a prevalent neurodegenerative autoimmune disease characterized by the infiltration of immune cells into the Central Nervous System (CNS), leading to inflammation, demyelination, and neurodegeneration. A critical early event in MS and its animal model, Experimental Autoimmune Encephalomyelitis (EAE), is the disruption of the Blood-Spinal Cord Barrier (BSCB), which allows pathogenic immune cells to cross from the periphery into the CNS.

While ketogenic diets (KD) have shown promise in preclinical models for restoring motor function and vision in EAE, the specific cellular and molecular mechanisms driving this therapeutic efficacy remain poorly understood. Furthermore, most existing studies focus on prophylactic (preventative) administration or lymphocyte-centric mechanisms, often neglecting sex differences and the role of innate immune cells (myeloid cells) in barrier integrity.

2. Methodology

The study utilized a therapeutic intervention paradigm in the MOG35-55-induced EAE mouse model to mimic clinical scenarios where patients initiate treatment after symptom onset.

• Subjects: Wild-type C57BL/6J mice and a transgenic "SMART-Fox" strain (C57BL/6J background expressing Foxp3-GFP and IL-17A reporter) were used. Both male and female mice were included to assess sex-specific responses.
• Dietary Intervention: Mice were fed a standard chow diet (CD) until the onset of motor symptoms (motor score ≥ 1). At symptom onset, mice were switched to either a control diet (CD) or a specific Ketogenic Diet (KD) enriched in medium-chain triglycerides (MCTs) and ω-3 fatty acids. The KD was maintained for up to 14 days.
• Experimental Timepoints:
  • Peak Disease: 5–7 days post-symptom onset (DPSO).
  • Late Disease: 13–15 DPSO.
  • Delayed Intervention: A subset of mice began KD treatment 6–8 days after symptom onset to test efficacy in established disease.
• Analytical Techniques:
  • Multiparameter Flow Cytometry: Performed on Spinal Cord (SC), Blood, and Bone Marrow (BM) to profile immune cell populations (T cells, B cells, neutrophils, monocytes/macrophages, microglia).
  • BSCB Permeability Assay: Intraperitoneal injection of Sodium Fluorescein (NaFl) to quantify barrier leakage.
  • ELISA: Quantification of cytokines (IL-1β, IL-6, CXCL2) in SC extracts.
  • Immunohistochemistry (IHC): Assessment of lesion size and cellularity.
  • t-SNE Analysis: Used to visualize high-dimensional flow cytometry data and identify specific cell subpopulations.

3. Key Contributions

This study provides a novel mechanistic framework for KD efficacy in MS, shifting the focus from purely lymphocyte suppression to myeloid cell regulation and BSCB resealing. Key contributions include:

1. Demonstration of Therapeutic Timing: Proving that KD is effective even when initiated after symptom onset (both immediately and with a 1-week delay), suggesting utility for acute relapses.
2. BSCB Resealing Mechanism: Identifying that KD accelerates the resealing of the compromised BSCB, a primary driver of immune cell infiltration.
3. Sex-Neutral Efficacy: Showing that while peripheral immune responses differ slightly between sexes, the core therapeutic outcomes (motor recovery, barrier resealing, and CNS infiltration reduction) are consistent in both males and females.
4. Myeloid Cell Reprogramming: Revealing that KD does not merely deplete immune cells but selectively preserves anti-inflammatory, pro-resolution subpopulations of neutrophils and monocytes/macrophages.

4. Key Results

A. Functional Recovery and Barrier Integrity

• Motor Function: KD-fed mice showed rapid motor recovery starting within 2 days (females) to 4 days (males) of diet initiation. This recovery persisted for the duration of the study.
• BSCB Resealing:
  • EAE mice exhibited significant BSCB permeability at symptom onset.
  • KD treatment reduced BSCB permeability by >50% within 3 days of initiation in both sexes, accelerating the natural resealing process observed in the CD group.
  • Delayed Intervention: Even when KD was started 1 week after symptom onset, it successfully promoted BSCB resealing and improved motor scores.
• Cytokine Reduction: KD significantly reduced levels of secreted, bioactive IL-1β in the spinal cord. IL-1β is a primary driver of BSCB disruption via inflammasome activation.

B. Immune Cell Profiling (Spinal Cord vs. Periphery)

• Spinal Cord (SC) Infiltration:
  • Total Reduction: KD caused a dramatic reduction (>90% for neutrophils, >70% for T cells) in total CD45HI immune cell infiltration in the SC by "Late" disease.
  • Neutrophils: KD reduced neutrophil abundance by >90%. Crucially, the remaining neutrophils exhibited a pro-resolution phenotype: reduced Ly6G (migration marker), high CD62L (naïve/homing marker), and high CD44.
  • Monocytes/Macrophages: KD reduced pro-inflammatory Ly6C+ monocytes/macrophages (>70-90% reduction) while preserving Ly6C- non-classical monocytes associated with tissue repair.
• Peripheral Blood:
  • Paradoxically, KD increased circulating myeloid cells (neutrophils and monocytes) in the blood at "Peak" disease.
  • This suggests the KD prevents these cells from migrating into the CNS rather than suppressing their production in the bone marrow (BM cell counts remained stable or decreased).

C. Mechanistic Insights

• Inflammasome Inhibition: The reduction in IL-1β suggests KD inhibits the NLRP3 inflammasome, likely via β-hydroxybutyrate (β-HB) signaling (potentially through HCA2R or HDAC3 inhibition), thereby preventing the cytokine cascade that opens the BSCB.
• Metabolic Reprogramming: The preservation of pro-resolution myeloid cells may be driven by the metabolic shift from glycolysis (required for pro-inflammatory activation) to oxidative phosphorylation, which is favored by the low-carbohydrate KD environment.

5. Significance and Implications

• Clinical Translation: The findings support the potential of KD as a rapid, reversible, and safe therapeutic strategy for MS patients experiencing acute relapses or those with Clinically Isolated Syndrome (CIS) who are treatment-naïve.
• Barrier-Centric Therapy: The study highlights that restoring blood-CNS barrier integrity is a viable therapeutic target. By resealing the barrier, the diet limits the "fuel" (immune cells) for ongoing CNS inflammation.
• Broad Applicability: The mechanism (BSCB resealing and myeloid cell modulation) suggests KD could benefit other neurodegenerative diseases involving barrier dysfunction and myeloid-driven inflammation, such as Alzheimer's, Parkinson's, and ALS.
• Sex Differences: The study validates that while peripheral immune profiles differ between sexes, the therapeutic mechanism of KD is robust across both, addressing a gap in previous EAE research that predominantly used female mice.

In conclusion, this paper establishes that a ketogenic diet ameliorates MS-like pathology not just by suppressing the immune system, but by accelerating the resealing of the blood-spinal cord barrier and reprogramming innate immune cells toward a healing phenotype, thereby halting the cycle of inflammation and promoting functional recovery.